Status: Recruiting
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
This clinical trial is conducted in two parts. Part One employs a randomized, partially blinded, dose-escalation, partially active-controlled design. Part Two utilizes a randomized, blinded, placebo-controlled design. Part One is divided into four stages based on age and vaccine dose levels. Part Two consists of the 2-month-old vaccine/placebo groups.
Participants needed: 260
Trial details
Phase: Phase 1Age: 2-6Biological sex: AllType: InterventionalSponsor: CanSino Biologics Inc.Updated: Dec 31, 2025Locations: 1
Eligibility criteria
Participants aged 2 months (60-89 days), 3 months (90-119 days), 18-24 months, a... [+3]
Infants born prematurely (delivery before 37 weeks gestation) or with low birth... [+28]